Literature DB >> 38968

Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89,406 in healthy volunteers.

T L Svendsen, O Hartling, J Trap-Jensen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 38968     DOI: 10.1007/bf00618509

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  23 in total

1.  Experience with pindolol, a betareceptor blocker, in the treatment of hypertension.

Authors:  J H Atterhög; H Dunér; B Pernow
Journal:  Am J Med       Date:  1976-05-31       Impact factor: 4.965

2.  Comparative hemodynamic studies in man of adrenergic bepta-1-receptors agents without (h 93/26 equal to metoprolol) or with (h 87/07) intrinsic sympathicomimetic activity.

Authors:  J Stenberg; H Wasir; A Amery; R Sannerstedt; L Werkö
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975

3.  The pharmacology of atenolol.

Authors:  A M Barrett
Journal:  Postgrad Med J       Date:  1977       Impact factor: 2.401

4.  Hemodynamic effects of beta-adrenergic blockade with pindolol, oxprenolol, propranolol and bufetolol hydrochloride in essential hypertension.

Authors:  H Tsukiyama; K Otsuka; K Miyamoto; M Hashimoto; S Yasutake
Journal:  Jpn Circ J       Date:  1976-06

5.  The action of intravenous oxprenolol, practolol, propranolol and sotalol on acute exercise tolerance in angina pectoris: the effect on heart rate and the electrocardiogram.

Authors:  B N Prichard; W H Aellig; G A Richardson
Journal:  Postgrad Med J       Date:  1970-11       Impact factor: 2.401

6.  The Minnesota impedance cardiograph- theory and applications.

Authors:  W G Kubicek; J Kottke; M U Ramos; R P Patterson; D A Witsoe; J W Labree; W Remole; T E Layman; H Schoening; J T Garamela
Journal:  Biomed Eng       Date:  1974-09

7.  The specific resistance of canine blood at body temperature.

Authors:  L A Geddes; C P Da Costa
Journal:  IEEE Trans Biomed Eng       Date:  1973-01       Impact factor: 4.538

8.  Measurement of cardiac output by electrical impedance at rest and during exercise.

Authors:  J C Denniston; J T Maher; J T Reeves; J C Cruz; A Cymerman; R F Grover
Journal:  J Appl Physiol       Date:  1976-01       Impact factor: 3.531

9.  Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.

Authors:  L Hansson
Journal:  Acta Med Scand Suppl       Date:  1973

10.  Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris.

Authors:  H Aström; H Vallin
Journal:  Br Heart J       Date:  1974-12
View more
  44 in total

1.  Selectivity of antagonist and partial agonist activity of celiprolol in normal subjects.

Authors:  N M Wheeldon; D G McDevitt; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

2.  Differential cardiovascular effects of propranolol, atenolol, and pindolol measured by impedance cardiography.

Authors:  S H Thomas; R C Cooper; M Ekwuru; S Fletcher; J Gilbody; T S Husseyin; M Ishaque; R Jagathesan; G Reddy; S E Smith
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Hemodynamic effects of pindolol and atenolol at rest and during isometric exercise: a noninvasive study with healthy volunteers.

Authors:  J M Rapola; T J Pellinen; P Koskinen; L Toivonen; M S Nieminen
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

4.  Preclinical evaluation of an 18F-labelled beta1-adrenoceptor selective radioligand based on ICI 89,406.

Authors:  Marilyn P Law; Stefan Wagner; Klaus Kopka; Christiane Renner; Victor W Pike; Otmar Schober; Michael Schäfers
Journal:  Nucl Med Biol       Date:  2010-05       Impact factor: 2.408

5.  Effect of celiprolol therapy on arterial dilatation in experimental hypertension.

Authors:  J P Tolvanen; X Wu; M Kähönen; K Sallinen; H Mäkynen; A Pekki; I Pörsti
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 6.  Pindolol--the pharmacology of a partial agonist.

Authors:  B J Clark; K Menninger; A Bertholet
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

7.  Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.

Authors:  P C O'Connor; M J Finch; D W Harron; P A Meredith; D G McDevitt; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

8.  The effect of intrinsic sympathomimetic activity of beta-adrenoceptor blockers on circadian heart rate.

Authors:  P Fitscha; B Tiso; W Meisner; D Spitzer
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

9.  Effect of beta-adrenoceptor antagonists on prevalence of peripheral vascular symptoms in hypertensive patients.

Authors:  J A Steiner; R Cooper; K McPherson; A J Riley
Journal:  Br J Clin Pharmacol       Date:  1982-12       Impact factor: 4.335

10.  (+/-)[125Iodo] cyanopindolol, a new ligand for beta-adrenoceptors: identification and quantitation of subclasses of beta-adrenoceptors in guinea pig.

Authors:  G Engel; D Hoyer; R Berthold; H Wagner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.